[1]
2025. An Update on the Innovative Mechanistic Modes for the Avoidance of Heart Failure with Preserved Ejection Fraction Using Glucagon Like Peptide 1 Receptor Agonism Particularly in Type 2 Diabetes Mellitus & Metabolic Syndrome: A Review: Review Article. International Journal of Research in Medical and Clinical Science. 3, 02 (Aug. 2025), 04–28. DOI:https://doi.org/10.70829/ijrmcs.v03.i02.002.